Nomura Asset Management Co. Ltd. trimmed its position in Waters Corporation (NYSE:WAT) by 13.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 323,344 shares of the medical instruments supplier’s stock after selling 52,055 shares during the quarter. Nomura Asset Management Co. Ltd. owned approximately 0.41% of Waters worth $58,047,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in WAT. Oppenheimer Asset Management Inc. raised its holdings in Waters by 0.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after acquiring an additional 2 shares during the period. ETF Managers Group LLC bought a new position in Waters in the 2nd quarter valued at about $106,000. Intellectus Partners LLC raised its holdings in Waters by 4.9% in the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after acquiring an additional 31 shares during the period. First Manhattan Co. bought a new position in Waters in the 2nd quarter valued at about $130,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new position in shares of Waters during the 2nd quarter worth approximately $160,000. 92.29% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have issued reports on WAT shares. Deutsche Bank increased their target price on shares of Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Zacks Investment Research upgraded shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 target price on the stock in a research report on Monday, October 23rd. Barclays increased their target price on shares of Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Bank of America increased their target price on shares of Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Finally, Cowen restated a “hold” rating and set a $190.00 target price on shares of Waters in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $193.62.
Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The business had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the business posted $1.57 EPS. equities research analysts predict that Waters Corporation will post 7.42 earnings per share for the current year.
In related news, Director Thomas P. Salice sold 3,500 shares of the stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $200.03, for a total transaction of $700,105.00. Following the sale, the director now owns 20,349 shares in the company, valued at approximately $4,070,410.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Elizabeth B. Rae sold 12,000 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the sale, the senior vice president now owns 18,129 shares in the company, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. Insiders have sold a total of 60,813 shares of company stock worth $11,820,747 in the last quarter. 5.07% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.com-unik.info/2017/12/05/waters-corporation-wat-shares-sold-by-nomura-asset-management-co-ltd.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
What are top analysts saying about Waters Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Waters Corporation and related companies.